Fndc5/irisin has been found to be reduced in AD brain, and forced expression of Fndc5 in the brain or bilateral intrahippocampal injection of recombinant irisin can rescue hippocampal synaptic plasticity as well as cognitive dysfunction in mouse AD models [15]. Here, FNDC5 is linked to Alzheimer disease.